Company news
Filament Health Corp news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Filament Health announces voluntary delisting from Cboe Canada
May 19, 2025
Filament Health announces first quarter 2025 financial results and operational highlights
May 8, 2025
Filament Health announces FDA authorization of phase 2 clinical trial studying PEX010, the company's botanical psilocybin drug candidate, in opioid use disorder
April 9, 2025
Filament Health announces private placement and intention to voluntarily delist from Cboe Canada
April 3, 2025
Filament Health reports Q4 and year end 2024 financial results and operational highlights
April 1, 2025
Filament Health announces positive data from phase 2 study of PEX010 in patients with alcohol use disorder
March 17, 2025
Filament Health announces shipment of botanical psilocybin to the University of wisconsin-madison
January 21, 2025
Filament Health announces import of coca leaf from Peru by joint venture magdalena biosciences
December 16, 2024
Filament Health announces third quarter 2024 financial results and Operational Highlights
November 14, 2024
Filament Health announces issuance of common shares to negev capital investments limited pursuant to advisory agreement
October 4, 2024
Filament Health announces second quarter 2024 Financial results and Operational Highlights
August 14, 2024
Filament Health announces major intellectual property expansion
August 13, 2024
Filament Health announces closing of warrant exercise, note conversion and concurrent private placement of common shares
June 12, 2024
Filament Health announces authorization of phase 2 clinical trial for PEX010 in the treatment of methamphetamine use disorder
June 3, 2024
Filament Health announces warrant exercise and note conversion by negev capital and concurrent private placement of common shares to Benjamin Lightburn, Chief Executive Officer
June 3, 2024
Filament Health announces first quarter 2024 financial results and Operational Highlights
May 14, 2024
Filament Health announces change to board of directors
May 3, 2024
Filament Health to discuss its drug development platform in fireside chat with water tower research on April 4, 2024 at 12PM et
April 3, 2024
Filament Health reports Q4 and year end 2023 financial results and operational highlights
April 2, 2024
Filament Health announces appointment of Michael Messinger to its board of directors
March 28, 2024
Filament Health announces shipments of botanical psilocybin to four countries for clinical investigation
March 19, 2024
Filament Health announces FDA opening of IND application for substance abuse disorder
February 20, 2024
Filament Health completes the first export of botanical psilocybin to Israel
February 15, 2024
Filament Health announces FDA opening of investigational new drug application for substance use disorders
January 31, 2024
Filament Health completes the first export of botanical psilocybin to Australia
January 17, 2024
Filament Health announces change to board of directors
January 2, 2024
Filament Health announces termination of proposed business combination with jupiter acquisition corporation
December 20, 2023
Filament Health announces termination of shareholder meeting and engagement of donohoe advisory for compliance expertise
December 18, 2023
Filament Health announces adjournment of special meeting
December 11, 2023
Filament Health files amended pro forma financial statements
December 7, 2023
Filament Health announces signing of definitive agreement for convertible note financing, closing of C$900,000 non-brokered private placement financing, founder-led note offering and other updates related to upcoming special meeting and Proposed Business Combination
December 6, 2023
Filament Health announces non-binding agreement for up to US$14 million in financing
November 29, 2023
Filament Health receives authorization from Health Canada for Phase 2 clinical trial at UBC
November 29, 2023
Filament Health signs non-binding term sheet for convertible note in connection with planned Business Combination
November 23, 2023
Filament Health announces third quarter 2023 financial results and Operational Highlights
November 14, 2023
Filament Health and NASDAQ-listed spac jupiter acquisition corporation announce Form F-4 registration statement declared effective by the U.S. securities and Exchange Commission and mailing of definitive proxy statement
November 14, 2023
Filament Health Announces Annual General Meeting Voting Results
November 8, 2023
Filament Health announces Health Canada authorization for phase 2 clinical trial studying botanical psilocybin for opioid use disorder
October 10, 2023
Filament Health Corp. announces non-brokered private placement unit offering led by Negev Capital
September 29, 2023
Filament Health and jaguar health joint venture magdalena biosciences completes import of coca leaf from Peru
September 21, 2023
Filament Health enters licensing agreement with reset pharma
August 31, 2023
Filament Health and NASDAQ-listed SPAC jupiter acquisition corp. announce filing of SEC registration statement
August 15, 2023
Filament Health announces first quarter 2023 financial results and refiles Q1 2023 interim financial statements and MD&A
August 15, 2023
Filament Health announces FDA approval of two clinical trials studying its botanical psilocybin drug candidate PEX010
August 8, 2023
Filament Health announces upsizing and closing of $2,500,000 non-brokered private placement financing
July 24, 2023
Filament Health Corp. announces non-brokered private placement unit offering of up to C$2,000,000
July 19, 2023
Filament Health Corp. to list on NASDAQ through business combination with jupiter acquisition corporation
July 19, 2023
Filament Health announces change of auditor
July 14, 2023
Filament Health to supply psilocybin for recipients of The Canadian Institutes of Health Research psilocybin Operating Grants
July 6, 2023
Filament Health enters exclusive licensing agreement with NeoLumina bioscience inc.
June 30, 2023
Decks
- SPAC Merger (October 2023)
SPAC merger · 27 slides · Oct 2, 2023
- SPAC Merger (July 2023)
SPAC merger · 28 slides · Jul 24, 2023